Skip to main
  1. Stocks
  2. Sabra Health Care
  3. Forecast
SBRA

SBRA Stock Forecast & Price Target

SBRA Analyst Ratings

Based on 10 analyst ratings
Hold
Strong Buy 10%
Buy 20%
Hold 70%
Sell 0%
Strong Sell 0%

Bulls say

Sabra Health Care REIT is benefiting from stronger senior housing and skilled nursing fundamentals, highlighted by 2Q26 occupancy at 89.9% and same-store SHOP NOI growth of 14.4% in 1Q26, while management expects SHOP to reach 40% of gross assets by FYE26. The company also delivered concrete portfolio gains through the Avamere re-tenanting, which should lift annualized cash rent to about $53 million, plus more than $9 million of incremental annual cash NOI from other transactions and a $200 million RCA mortgage repayment that improved net debt-to-EBITDA from 5.0x to 4.8x. Raised 2026 guidance for normalized AFFO per share to $1.59-$1.61, supported by a 6.0% dividend yield that is covered by cash flow and a strong pipeline of accretive investments, reinforces a positive fundamental outlook.

Bears say

Sabra Health Care REIT is pressured by weak tenant fundamentals, because recovery of its investments can be limited if operators face difficult operating conditions, regulatory failures, or reimbursement cuts from Medicaid, Medicare, and other third-party payers. Its balance sheet and growth capacity also look vulnerable, as the company relies on external capital, carries meaningful debt, and faces re-leasing risk if properties cannot be redeployed quickly or at attractive rates. Near-term earnings quality appears challenged by a reduced repayment on the $300 million mortgage scheduled to mature on 11/1/26, higher FY26 G&A expense guidance of $61 million, and the risk that higher capital costs and tougher competition make new investments less accretive.

SBRA has been analyzed by 10 analysts, with a consensus rating of Hold. 10% of analysts recommend a Strong Buy, 20% recommend Buy, 70% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sabra Health Care and is not a guaranteed prediction by Public.com or investment advice.

SBRA Analyst Forecast & Price Prediction

Get the latest SBRA stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in SBRA

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sabra Health Care (SBRA) Forecast

Analysts have given SBRA a Hold based on their latest research and market trends.

According to 10 analysts, SBRA has a Hold consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sabra Health Care (SBRA)


SBRA Analyst Forecast & Price Prediction

Get the latest SBRA stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in SBRA

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover SBRA stock data and trends